BriaCell Therapeutics Cor... (BCTX)
NASDAQ: BCTX
· Real-Time Price · USD
0.74
0.00 (0.14%)
At close: Aug 15, 2025, 3:59 PM
0.72
-2.70%
After-hours: Aug 15, 2025, 07:39 PM EDT
BriaCell Therapeutics Cash Flow Statement
Financials in USD. Fiscal
year is
August - July.
| Fiscal Year | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Apr 30, 2025 | Jan 31, 2025 | Oct 31, 2024 | Jul 31, 2024 | Apr 30, 2024 | Jan 31, 2024 | Oct 31, 2023 | Jul 31, 2023 | Apr 30, 2023 | Jan 31, 2023 | Oct 31, 2022 | Jul 31, 2022 | Apr 30, 2022 | Jan 31, 2022 | Oct 31, 2021 | Jul 31, 2021 | Apr 30, 2021 | Jan 31, 2021 | Oct 31, 2020 |
Net Income | -19.64M | -11.72M | -16.72M | -4.93M | -6.1M | -12.69M | -13.24M | -20.3M | -33.63M | -33.58M | -25.56M | -26.84M | -13.81M | -5.96M | -2.45M | -428.33K | 1.67M | -1.72M | -2.8M |
Depreciation & Amortization | 151.81K | 128.97K | 106.74K | 83.9K | 15.27K | 15.27K | 15.27K | 15.27K | 15.27K | 15.27K | 15.27K | 15.27K | 15.26K | 15.56K | 15.56K | 15.26K | 15.29K | 14.21K | 13.93K |
Stock-Based Compensation | 1.15M | 1.32M | 1.54M | 1.8M | 1.96M | 1.85M | 1.62M | 2.19M | 1.53M | 2.83M | 3.67M | 3.07M | 3.16M | 3.59M | 2.49M | 1.97M | 2.01M | 197.51 | 192.63 |
Other Working Capital | 2.11M | 6.5M | 4.97M | 5.74M | 388.09K | -5.23M | -3.56M | -4.19M | 851.38K | -158.2K | -53.28K | -341.43K | -1.31M | -3.03M | -3.32M | -2.89M | -2.89M | 435.03K | 382.82K |
Other Non-Cash Items | -4.72M | -18.83M | -16.48M | -31.46M | -32.02M | -18.33M | -12.28M | -2.12M | 14.55M | 15.12M | 7.43M | 11.55M | 1.79M | 1.76M | 1.81M | 1.82M | 1.65K | 6.01K | 10.72K |
Deferred Income Tax | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 105.79K | -959.78K | -8.73M | -8.73M | -8.84M | -7.78M | 0.00 | 0.00 |
Change in Working Capital | -1.02M | 3.79M | 4.77M | 7.05M | 1.81M | -2.11M | -3.92M | -3.53M | 1.38M | -39.03K | 196K | -391.29K | -1.3M | -2.49M | -2.61M | -2.28M | -2.02M | 1.21M | 2.36M |
Operating Cash Flow | -24.07M | -21.99M | -23.48M | -24.13M | -31.01M | -31.26M | -27.81M | -23.74M | -16.15M | -15.64M | -14.25M | -12.48M | -11.1M | -11.82M | -9.47M | -7.75M | -6.1M | -496.89K | -410.07K |
Capital Expenditures | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cash Acquisitions | -255K | -375K | -300K | -225K | -225K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Purchase of Investments | n/a | -304.27K | -304.27K | -304.27K | -304.27K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Sales Maturities Of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Investing Acitivies | -456.8K | -456.8K | -456.8K | -456.8K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Investing Cash Flow | -711.8K | -831.8K | -756.8K | -681.8K | -225K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -13.18 | 828.13 | 1.65K | 1.65K | 6.44K | -1.36K | -2.71K |
Debt Repayment | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 207.74 | -574.44K | -359.83K | -332.72K | -178.69K | 473.08K | 410.39K |
Common Stock Repurchased | n/a | n/a | n/a | n/a | n/a | -0.5 | -412.92 | -47.71K | -150.37K | -171.77K | -12.95M | -12.91M | -12.8M | -12.78M | n/a | n/a | n/a | n/a | n/a |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | 821.02K | 821.02K | 293.25K | n/a | 1.37M | 1.37M | 1.37M | 1.37M | -55.52K | 1.32M | 2.59M | 2.59M | 19.05M | 11.58M | 10.36M | 10.37M | -6.01M | 81.87K | 32.83K |
Financial Cash Flow | 36.31M | 21.6M | 16.38M | 4.42M | 4M | 4M | 4M | 3.95M | -205.9K | 1.16M | -3.79M | -3.74M | 34.69M | 59.81M | 64.97M | 65M | 26.91M | 447.63K | 388.38K |
Net Cash Flow | 11.52M | -1.23M | -7.85M | -20.39M | -27.23M | -27.26M | -23.81M | -19.79M | -16.36M | -14.48M | -18.04M | -16.23M | 24.45M | 47.98M | 55.48M | 57.25M | 20.02M | -65.31K | -52.26K |
Free Cash Flow | -24.07M | -21.99M | -23.48M | -24.13M | -31.01M | -31.26M | -27.81M | -23.74M | -16.15M | -15.64M | -14.25M | -12.48M | -11.1M | -11.82M | -9.47M | -7.75M | -6.1M | -496.89K | -410.07K |